Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

6.514 -0.106 (-1.60%)
Streaming Delayed Price Updated: 10:07 AM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
39 40 Next >
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in May 18 NYSE Trading Bell Ceremony
Via Investor Brand Network
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
From Cybin Inc.
Via Business Wire
Psychedelic Stock Gainers And Losers From May 16, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
Takeaways from Benzinga’s Psychedelics Capital Conference
Via Investor Brand Network
Study Discovers Mechanisms Behind Relapse After Treatment of MDD
Via Investor Brand Network
Research Finds That Mushrooms May Have Their Own Language
Via Investor Brand Network
2 Of The 5 Cannabis Categories Advanced Slightly During Second Week Of May
The cannabis sector consists of 5 distinct categories, each performing differently from the other. Here, the stock performances during the second week of May, YTD and from the 2021 peak. 
Via Talk Markets
Psychedelic Compounds-Based Stocks Index Imploding
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 12, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 11, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
Study Indicates People Are Cautious About Psilocybin Therapy, More Awareness Needed
Via Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright Global Investment Conference
Via Investor Brand Network
Cybin to Present at the H.C. Wainwright Global Investment Conference on May 25, 2022
From Cybin Inc.
Via Business Wire
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Kernel Share Preliminary Results from Flow Feasibility Study
Via Investor Brand Network
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs
Psychedelics policy action took center stage this week. 
Via Benzinga
American Billionaire Entrepreneurs Bet Millions on Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman... 
Via FinancialNewsMedia
Exposures Product Safety
Psychedelic Stock Gainers And Losers From May 9, 2022
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
U.S. Army Sued Over Discharging Soldiers with Substance-Abuse Issues
Via Investor Brand Network
Topics Lawsuit
Exposures Financial Legal
Pilot Study By Cybin Shows That Ketamine Modifies Connectivity Between Brain Regions
Cybin Inc. (NYSE:CYBN) and Kernel, two companies that undertook a joint feasibility study to evaluate the effects ketamine has on blood flow in the brain in late March,&nbs 
Via Benzinga
Psychedelic Stocks Continue To Decline In May
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue. 
Via Talk Markets
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16 
Via Benzinga
Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial
Via Investor Brand Network
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS: 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy
Via Investor Brand Network
Cybin Announces CYB003 Poster to be Presented at the ‘From Research to Reality’ Global Summit on Psychedelic-Assisted Therapies and Medicine
From Cybin Inc.
Via Business Wire
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30 
Via Benzinga
Study Says Antidepressants Don’t Meaningfully Improve Depressed People’s Well-Being
Via Investor Brand Network
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.